Professor Miles Houslay, PhD, FRSE, FMedSci

Chief Scientific Officer

Miles is a pioneer and key opinion leader in cAMP phosphodiesterases (PDE) and cell signalling research (H-Index = 81; >450 publications) with a strong track record of value creation through industrial collaborations. Worked at key stages with Celgene on their PDE4 development program, which led to Apremilast (Otezla), and with Pfizer on their PDE5 development programme, which led to Sildenafil (Viagra).

An ambitious, vibrant, growing, customer-centric company

get in touch